Register Login

Thrombophilia

Inpatient Thrombophilia Testing

Another message from colleague and friend Kelly Townsend, Tricore Reference Laboratories, Albuquerque. Hi George, at one of our large teaching hospitals, we are working with the Internal Medicine department to establish “best practices” for ordering thrombophilia testing on inpatients. Has anyone out there successfully implemented guidelines they are willing to share? Any recent references would also be […]
read more

Anti-PF4/Protamine HIT

Hans Zwerger, Produktspezialist at CoaChrom Diagnostica, Vienna, Austria introduced me to an important clinical issue, anti-platelet factor 4 (PF4)/protamine antibodies that are implicated in heparin-induced thrombocytopenia with thrombosis (HIT). As you know, cardiologists employ high doses of standard unfractionated heparin during coronary artery bypass graft surgery, which anesthetists and anesthesiologists measure using the activated clotting time […]
read more

Rapid HIT Assays

Informal discussions with Ginger Weeden and Lucinda Lojka from Bio-Rad, Incmade me curious about rapid assays for the antibody that causes heparin-induced thrombocytopenia with thrombosis (HIT), anti-heparin/PF4. In North America we typically screen with one of three enzyme immunoassay (EIA) methods, from GTI Diagnostics Inc., Waukesha, WI, USA, PF4 Enhanced®: GTI PF4 Enhanced Package Insert; Hyphen Bio-med, Neuville-Sur-Oise, France, Zymutest HIA® Assay; or Diagnostica Stago, […]
read more